Massive Sell-Offs: These 10 Stocks Shockingly Nosedived

6. ADMA Biologics, Inc. (NASDAQ:ADMA)

ADMA Biologics fell by 14.7 percent week-on-week, closing Friday at $17.74 versus the $20.81 on June 13, as investors took path from three of its executives’ recent disposition of shares in the company.

In a regulatory filing, ADMA Biologics, Inc. (NASDAQ:ADMA) President and CEO Adam Grossman sold 21,000 ADMA shares at a price of $20.81 apiece on June 16 for a total value of $437,010. On the same day, he acquired 15,000 shares at a price of $5.4 apiece for a total of $81,000.

ADMA Biologics, Inc. (NASDAQ:ADMA) said that the transaction was in line with the Rule 10b5-1 trading plan entered into between Grossman and Fidelity Brokerage Services LLC.

The transaction followed sales activities made by the company’s chairman, Steven Elms, and founder and vice chairman, Jerrold Grossman.

For his part, Elms sold 425,621 of his shares in the company for an aggregate market value of $9.3 million, while Jerrold disposed of  10,000 shares at an aggregate market value of $206,100.

It is worth noting that ADMA Biologics, Inc.’s (NASDAQ:ADMA) closing price on Friday marked its sixth straight day of decline.